Related Experiment Video
Updated: May 5, 2026
Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury
Published on: December 17, 2014
The Effect of Tissue Inhibitor of Metalloproteinases on Scar Formation after Spinal Cord Injury
Raveena R Mishra1, Brooke E Nielsen1, Melissa A Trudrung1
1Department of Neurosurgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA.
Abstract:
Spinal cord injury (SCI) often results in permanent loss of motor and sensory function. After SCI, the blood-spinal cord barrier (BSCB) is disrupted, causing the infiltration of neutrophils and macrophages, which secrete several kinds of cytokines, as well as matrix metalloproteinases (MMPs). MMPs are proteases capable of degrading various extracellular matrix (ECM) proteins, as well as many non-matrix substrates. The tissue inhibitor of MMPs (TIMP)-1 is significantly upregulated post-SCI and operates via MMP-dependent and MMP-independent pathways. Through the MMP-dependent pathway, TIMP-1 directly reduces inflammation and destruction of the ECM by binding and blocking the catalytic domains of MMPs. Thus, TIMP-1 helps preserve the BSCB and reduces immune cell infiltration. The MMP-independent pathway involves TIMP-1's cytokine-like functions, in which it binds specific TIMP surface receptors. Through receptor binding, TIMP-1 can stimulate the proliferation of several types of cells, including keratinocytes, aortic smooth muscle cells, skin epithelial cells, corneal epithelial cells, and astrocytes. TIMP-1 induces astrocyte proliferation, modulates microglia activation, and increases myelination and neurite extension in the central nervous system (CNS). In addition, TIMP-1 also regulates apoptosis and promotes cell survival through direct signaling. This review provides a comprehensive assessment of TIMP-1, specifically regarding its contribution to inflammation, ECM remodeling, and scar formation after SCI.
Insights
Tissue inhibitor of metalloproteinases-1 (TIMP-1) plays a dual role in spinal cord injury (SCI) recovery. It reduces inflammation and preserves the blood-spinal cord barrier (BSCB) via MMP-dependent and independent pathways.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Spinal cord injury (SCI) leads to motor and sensory deficits due to blood-spinal cord barrier (BSCB) disruption.
- Neutrophil and macrophage infiltration releases cytokines and matrix metalloproteinases (MMPs) that degrade extracellular matrix (ECM).
- Tissue inhibitor of metalloproteinases-1 (TIMP-1) is upregulated after SCI, influencing outcomes through MMP-dependent and independent mechanisms.
Purpose of the Study:
- To comprehensively review the multifaceted roles of TIMP-1 in the context of SCI.
- To elucidate TIMP-1's contribution to inflammation, ECM remodeling, and glial scar formation post-injury.
Main Methods:
- Literature review of studies investigating TIMP-1 expression and function after SCI.
- Analysis of MMP-dependent and MMP-independent pathways involving TIMP-1.
- Examination of TIMP-1's effects on cellular proliferation, immune modulation, and neural repair.
Main Results:
- TIMP-1 inhibits MMPs, reducing ECM degradation and preserving BSCB integrity, thereby limiting inflammation and immune cell infiltration.
- TIMP-1 exhibits cytokine-like functions, promoting proliferation of astrocytes and other cells, and enhancing myelination and neurite extension in the CNS.
- TIMP-1 regulates apoptosis and promotes cell survival through direct signaling pathways.
Conclusions:
- TIMP-1 is a critical modulator of the post-SCI environment, impacting inflammation, ECM dynamics, and neural repair.
- Understanding TIMP-1's dual roles is essential for developing therapeutic strategies targeting SCI recovery.
- TIMP-1's MMP-dependent and independent actions offer potential targets for mitigating secondary damage and promoting functional regeneration.
Related Concept Videos
01:24Healing II: Complications
01:25Secondary Spinal Cord Injury llI: Pathophysiology